News for Amylyx Pharmaceuticals Stock (AMLX)

The Top 3 Biotech Stocks to Buy in March 2024

InvestorPlace • 03/06/24

IMPORTANT INVESTOR ALERT: The Schall Law Firm Encourages Investors in Amylyx Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Accesswire • 03/06/24

Amylyx Pharmaceuticals, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before April 9, 2024 to Discuss Your Rights – AMLX

Accesswire • 03/06/24

ROSEN, LEADING INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMLX

PRNewsWire • 03/06/24

Amylyx Pharmaceuticals, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - AMLX

Accesswire • 03/03/24

Kirby McInerney LLP Reminds Amylyx Pharmaceuticals, Inc. (AMLX) Investors of Class Action Filing and Encourages Investors to Contact the Firm

Business Wire • 03/01/24

SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Amylyx To Contact Him Directly To Discuss Their Options

PRNewsWire • 02/29/24

Shareholders of Amylyx Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before April 9, 2024 to Discuss Your Rights – AMLX

Accesswire • 02/29/24

Amylyx Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 9, 2024 to Discuss Your Rights – AMLX

Accesswire • 02/26/24

AMLX LAWSUIT ALERT: The Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

PRNewsWire • 02/26/24

7 Oversold Russell 2000 Stocks to Add to Your February Buy List

InvestorPlace • 02/25/24

Shareholders of Amylyx Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before April 9, 2024 to Discuss Your Rights AMLX

Accesswire • 02/25/24

Amylyx Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Business Wire • 02/23/24

AMLX Stockholders with Significant Losses Should Contact Robbins LLP for Information About Their Rights and Remedies Against Amylyx Pharmaceuticals, Inc.

Business Wire • 02/23/24

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amylyx Pharmaceuticals, Inc. (AMLX)

Business Wire • 02/22/24

Amylyx Pharmaceuticals, Inc. (AMLX) Q4 2023 Earnings Call Transcript

Seeking Alpha • 02/22/24

Amylyx Stock Rockets As ALS Drug Tacks On Another Triple-Digit Quarter

Investors Business Daily • 02/22/24

Amylyx Pharmaceuticals, Inc. (AMLX) Misses Q4 Earnings Estimates

Zacks Investment Research • 02/22/24

Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

Business Wire • 02/22/24

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amylyx Pharmaceuticals, Inc. (AMLX)

Business Wire • 02/21/24

AMYLYX SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Amylyx To Contact Him Directly To Discuss Their Options

PRNewsWire • 02/21/24

AMLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Amylyx Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

PRNewsWire • 02/18/24

Amylyx Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 9, 2024 to Discuss Your Rights – AMLX

Accesswire • 02/18/24

Amylyx Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information – AMLX

Accesswire • 02/18/24

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Amylyx Pharmaceuticals, Inc. (AMLX) Investors

Business Wire • 02/16/24